SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-128613
Filing Date
2022-12-20
Accepted
2022-12-20 16:01:31
Documents
14
Period of Report
2022-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2233051d1_8k.htm   iXBRL 8-K 31813
2 EXHIBIT 10.1 tm2233051d1_ex10-1.htm EX-10.1 934925
6 GRAPHIC tm2233051d1_ex10-1img001.jpg GRAPHIC 3334
  Complete submission text file 0001104659-22-128613.txt   1352512

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA regn-20221219.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20221219_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20221219_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2233051d1_8k_htm.xml XML 3518
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 221474704
SIC: 2834 Pharmaceutical Preparations